Navigation Links
Glycos Biotechnologies Appoints Chief Executive Officer

Growing Biochemical Company Adds Industry Veteran Rich Cilento to Leadership Team

(PRWEB) January 27, 2010 -- Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Rich Cilento as Chief Executive Officer (CEO). A Venture Advisor for DFJ Mercury and currently Executive Chairman for GlycosBio, Cilento will now be responsible for the daily operations of the company as CEO.

“As Executive Chairman, Rich has made a tremendous impact on GlycosBio’s business in a very short amount of time helping to create the foundation for the company’s future growth,” said Dan Watkins, Managing Director of DFJ Mercury. “Rich has the business, technical and leadership experience necessary to drive and execute a successful go-to-market strategy while also remaining focused on the day-to-day operations of the company. This is an exciting time for GlycosBio and I’m confident with Rich’s guidance the company will achieve their business goals.”

With more than 20 years of leadership and technical experience in the petroleum, alternative energy, information technology and now biotechnology industries, Cilento has a proven track record of creating and managing successful businesses. Prior to his role as Executive Chairman for GlycosBio, Cilento held a variety of leadership positions throughout his career including his most recent position as Founder, President and CEO of FuelQuest, Inc. (acquired by Saracen Energy), a provider of on-demand supply chain management and tax automation software for suppliers, distributors, fuel buyers and traders in the global downstream energy marketplace. Cilento has also received national business honors winning the Ernst and Young Entrepreneur of the Year Award in 2006 for Energy Technology.

“GlycosBio has developed a truly unique technology to revolutionize the way the industry produces chemicals,” said Cilento. “These new biochemicals are 100% replacement products for the chemicals that are traditionally produced using fossil fuels and other unsustainable energy sources. Furthermore, to help meet the world’s growing demand for sustainable biochemicals and biofuels, GlycosBio’s techniques and processes create biochemicals that are an economic alternative to traditional chemical and fuel processes. With some of the industry’s brightest scientists and most experienced researchers on its team, GlycosBio has already attracted the attention of prominent biofuel and chemical companies worldwide and is on the verge of announcing many exciting commercialization efforts and scientific discoveries. I look forward to leading GlycosBio and our talented and dedicated team towards a vision of producing environmentally clean biochemicals that can compete head to head with traditional fossil fuels based petrochemicals.”

About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
2. Microchip Biotechnologies Raises $18.1M in Series B Financing
3. Epeius Biotechnologies to Partner at BIO Investor Forum
4. Variation Biotechnologies Names Jeff Baxter CEO
5. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
6. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
7. Andre Marion Joins Microchip Biotechnologies Board of Directors
8. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
9. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
10. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
11. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
Post Your Comments:
Related Image:
Glycos Biotechnologies Appoints Chief Executive Officer 
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to ... presentations offered in symposia, oral sessions, workshops, awards, and posters. The core ... of applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, ...
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):